Table 2 Longitudinal changes in patient-reported outcomes, residual kidney function, and HD treatment time
Assessment | Baseline | Week 6 | Week 12 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Incremental HD | Conventional HD | Incremental HD | Conventional HD | Incremental HD | Conventional HD | |||||||
N | Mean (95% CI) | N | Mean (95% CI) | N | Mean (95% CI) | N | Mean (95% CI) | N | Mean (95% CI) | N | Mean (95% CI) | |
Model 1 | ||||||||||||
 DSI | 20 | 39.5 (26.6, 52.4) | 21 | 41.5 (28.2, 55.7) | 20 | 29.2 (20.1, 38.2) | 21 | 27.5 (18.5, 36.6) | 20 | 25.8 (18.8, 32.9) | 21 | 24.8 (17.6, 32.0) |
 GAD-7 | 20 | 3.5 (1.0, 6.0) | 20 | 3.5 (1.0, 6.6) | 20 | 1.6 (0, 3.4) | 20 | 3.4 (1.5, 5.2) | 20 | 2.0 (0.6, 3.4) | 20 | 2.9 (1.5, 4.2) |
 PHQ-9 | 20 | 5.5 (2.7, 8.3) | 20 | 6.7 (3.8, 9.5) | 20 | 3.0 (1.5, 4.5) | 20 | 3.9 (2.4, 5.4) | 20 | 3.3 (1.9, 4.6) | 20 | 3.3 (2.0, 4.6) |
 Urine volume, mL/24 h | 23 | 914 (654–1174) | 25 | 1424 (976–1872) | 19 | 504 (335–673) | 17 | 553 (384–723) | 19 | 479 (288–670) | 19 | 484 (292–676) |
 Renal urea clearance, mL/min/1.73 m2 | 18 | 3.3 (2.0–4.5) | 17 | 4.1 (2.9–5.3) | 19 | 2.3 (1.6–2.9) | 17 | 2.3 (1.6–3.0) | 19 | 2.1 (1.4–2.8) | 19 | 2.0 (1.4–2.7) |
 HD treatment time (min) | 23 | 232.6 (24.8) | 25 | 209.2 (21.9) | 21 | 234.8 (27.3) | 21 | 214.8 (34.3) | 20 | 230.6 (23.5) | 20 | 211.4 (29.8) |
 Dialysis spKt/Va | 22 | 1.43 (1.32–1.53) | 21 | 1.30 (1.20–1.40) | 22 | 1.42 (1.32–1.51) | 18 | 1.40 (1.30–1.50) | 21 | 1.42 (1.34–1.50) | 18 | 1.36 (1.29–1.45) |
Model 2 | ||||||||||||
 DSI | 20 | 42.6 (29.5, 55.8) | 21 | 41.3 (27.5, 55.0) | 20 | 33.0 (23.4, 42.6) | 21 | 27.5 (17.3, 37.7) | 20 | 29.9 (21.2, 38.6) | 21 | 25.9 (16.6, 35.2) |
 GAD-7 | 20 | 3.6 (1.1, 6.2) | 20 | 3.1 (0.5, 5.8) | 20 | 1.7 (0, 3.6) | 20 | 3.0 (1.0, 5.0) | 20 | 2.1 (0.4, 3.9) | 20 | 3.1 (1.3, 4.9) |
 PHQ-9 | 20 | 5.6 (2.9, 8.4) | 20 | 6.7 (3.8, 9.5) | 20 | 3.1 (1.5, 4.8) | 20 | 4.1 (2.4, 5.9) | 20 | 3.4 (1.8, 5.0) | 20 | 3.7 (1.9, 5.4) |